← Back to JBIO

Jade Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 12/11/2024Mar 2024Filed 25/04/2025
−$56−$40−$25−$32−$38−$16−$25−$23
−$0.76−$0.57−$0.48−$0.86−$12.10−$5.16−$0.86−$0.83
615840283.23.22928

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.